Donatella Callegari
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Design and SAR Analysis of Covalent Inhibitors Driven by Hybrid QM/MM Simulations.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 05, 2020
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties.
Journal: European journal of medicinal chemistry
Published: July 29, 2019
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR.
Journal: European journal of medicinal chemistry
Published: July 09, 2018
L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib.
Journal: Chemical science
Published: November 03, 2017
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction.
Journal: Biochemical pharmacology
Published: September 08, 2017
Correction to Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8.
Journal: Journal of chemical information and modeling
Published: February 03, 2017
Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8.
Journal: Journal of chemical information and modeling
Published: January 13, 2017
Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.
Journal: Journal of medicinal chemistry
Published: December 23, 2016
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: March 02, 2016
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists.
Journal: Molecules (Basel, Switzerland)
Published: August 03, 2015
The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells.
Journal: Molecular nutrition & food research
Published: June 17, 2015
Δ(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system.
Journal: European journal of medicinal chemistry
Published: April 29, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026